Bioorganic and Medicinal Chemistry p. 593 - 602 (1996)
Update date:2022-08-03
Topics:
Kuyper, Lee F.
Garvey, Janice M.
Baccanari, David P.
Champness, John N.
Stammers, David K.
Beddell, Christopher R.
Conformationally restricted analogues of the antibacterial agent trimethoprim (TMP) were designed to mimic the conformation of drug observed in its complex with bacterial dihydrofolate reductase (DHFR). This conformation of TMP was achieved by linking the 4-amino function to the methylene group by one-and two-carbon bridges. A pyrrolo[2,3-d]pyrimidine, a dihydro analogue, and a tetrahydropyrido[2,3-d]pyrimidine were synthesized and tested as inhibitors of DHFR. One analogue showed activity equivalent to that of TMP against DHFR from three species of bacteria. An X-ray crystal structure of this inhibitor bound to Escherichia coli DHFR was determined to evaluate the structural consequences of the conformational restriction. Copyright
View MoreRefine Chemicals Science & Technology Technology Developing Co., Ltd.
Contact:+86-22-87899130
Address:No.12,west keyan road,Tianjin City
Beijing Cooperate Pharmaceutical Co.,Ltd
Contact:86-01060279497
Address:No.507,Building 4,Tianhua Street, Biomedicine industrial Base
Shanghai Yuanding Chem. Sci. & Tech. Co., Ltd.
website:http://www.shydtec.com
Contact:86-21-57721279
Address:Science and Technology Park, Songjiang District, Shanghai, China
Shenzhen Sunrising Industry Co., ltd.
Contact:+86 755 86571158 / 86571159 / 86571160
Address:2108 ZHENYE INT. BUSINESS CENTER,NO.3101-90 QIANHAI RD, NANSHAN,SHENZHEN, CHINA
Contact:0572-2722882
Address:1201,F3,xinghuibandao,
Doi:10.1021/ic9602052
(1996)Doi:10.1016/S0968-0896(96)00218-0
(1996)Doi:10.1021/jm001119l
(2001)Doi:10.1007/s10822-010-9371-3
(2010)Doi:10.1016/0040-4039(95)02300-3
(1996)Doi:10.1021/jm501827k
(2015)